EXHIBIT 99.1
STOCK OPTION AGREEMENT
THIS STOCK OPTION AGREEMENT (the "Agreement") is entered into as of June
19, 1998 by and between General Re Corporation, a Delaware corporation (the
"Grantee"), and Berkshire Hathaway Inc., a Delaware corporation (the "Grantor").
WHEREAS, the Grantee and the Grantor are entering into an Agreement and
Plan of Mergers, dated as of the date hereof (the "Merger Agreement"), which
provides, among other things, for the merger of a subsidiary of NBH, Inc., a
Delaware corporation, into Grantor (such merger, along with the other
transactions contemplated by the Merger Agreement, the "Transactions");
WHEREAS, as a condition and inducement to Grantee's willingness to enter
into the Merger Agreement, the Grantee has requested that the Grantor grant to
the Grantee an option to purchase up to 15,000,000 shares of Common Stock, par
value $0.50 per share, of the Grantor (the "Common Stock"), upon the terms and
subject to the conditions hereof; and
WHEREAS, in order to induce the Grantee to enter into the Merger
Agreement, the Grantor is willing to grant the Grantee the requested option.
NOW, THEREFORE, in consideration of the premises and the mutual covenants
and agreements set forth herein, the parties hereto agree as follows:
1. The Option; Exercise; Adjustments; Payment of Spread.
(a) Contemporaneously herewith the Grantee and the Grantor are
entering into the Merger Agreement. Subject to the other terms and
conditions set forth herein, the Grantor hereby grants to the Grantee an
irrevocable option (the "Option") to purchase up to 15,000,000 (as may be
adjusted as provided herein) shares of Common Stock (together with rights
attached thereto to purchase Series A Junior Participating Preferred Stock
of the Company issued pursuant to the Rights Agreement (the "Rights
Agreement") dated as of September 11, 1991 between the Company and Bank of
New York, as rights agent) (the "Shares") at a cash purchase price equal
to $283.71 per share (the "Purchase Price"). The Option may be exercised
by the Grantee, in whole or in part, at any time, or from time to time,
following the occurrence of one of the events set forth in Section 2(d)
hereof, and prior to the termination of the Option in accordance with the
terms of this Agreement.
(b) In the event the Grantee wishes to exercise the Option, the
Grantee shall send a written notice to the Grantor (the "Stock Exercise
Notice") specifying a date for the closing of such purchases (subject to
the HSR Act (as defined below) and applicable insurance regulatory
approvals) not later than 10 business days and not earlier than three
business days following the date such notice is given. In the event of any
change in the number of issued and outstanding shares of Common Stock by
reason of any stock dividend, stock split, split-up, recapitalization,
reorganization or other change in the corporate or capital structure of
the Grantor, the number and/or kind of Shares subject to this Option and
the purchase price per Share shall be appropriately adjusted to restore
the Grantee to its rights hereunder, including its right to purchase
Shares
representing 19.9% of the capital stock of the Grantor entitled to
vote generally for the election of the directors of the Grantor which is
issued and outstanding immediately prior to the exercise of the Option at
an aggregate purchase price equal to the Purchase Price multiplied by
15,000,000. In the event that any additional shares of Common Stock are
issued after the date of this Agreement (other than pursuant to an event
described in the preceding sentence), the number of Shares subject to this
Option shall be increased by 19.9% of the number of the additional shares
of Common Stock so issued (and such additional Shares shall have a
purchase price per share equal to the Purchase Price). Notwithstanding
anything in this Agreement, the number of shares subject to this Option
shall never exceed 19.9% of the outstanding shares of the Grantor.
(c) At any time when the Option is exercisable pursuant to the terms
of Section 1(a) hereof, the Grantee may elect, in lieu of exercising the
Option to purchase Shares as provided in Section 1(a) hereof, to send a
written notice to the Grantor (the "Cash Exercise Notice") specifying a
date not later than 20 business days and not earlier than 10 business days
following the date such notice is given on which date the Grantor shall
pay to the Grantee an amount in cash equal to the Spread (as hereinafter
defined) multiplied by all or such portion of the Shares subject to the
Option as Grantee shall specify in such notice. As used herein "Spread"
shall mean the excess, if any, over the Purchase Price of the higher of
(y) if applicable, the highest price per share of Common Stock (including
any brokerage commissions, transfer taxes and soliciting dealers' fees)
paid or proposed to be paid by any person pursuant to any Grenada Takeover
Proposal (as defined in the Merger Agreement) (the "Alternative Purchase
Price") or (z) the closing price of the shares of Common Stock on the NYSE
Composite Tape on the last trading day immediately prior to the date of
the Cash Exercise Notice (the "Closing Price"). If the Alternative
Purchase Price includes any property other than cash, the Alternative
Purchase Price shall be the sum of (i) the fixed cash amount, if any,
included in the Alternative Purchase Price plus (ii) the fair market value
of such other property. If such other property consists of securities with
an existing public trading market, the average of the closing prices (or
the average of the closing bid and asked prices if closing prices are
unavailable) for such securities in their principal public trading market
on the five trading days ending five days prior to the date of the Cash
Exercise Notice shall be deemed to equal the fair market value of such
property. If such other property consists of something other than cash or
securities with an existing public trading market and, as of the payment
date for the Spread, agreement on the value of such other property has not
been reached, the Alternative Purchase Price shall be deemed to equal the
Closing Price. Upon the Grantee's exercise of its right to receive cash
pursuant to this Section 1(c), the obligations of the Grantor to deliver
Shares pursuant to Section 3 shall be terminated with respect to such
number of Shares for which the Grantee shall have been paid the Spread.
2. Conditions to Delivery of Shares. The Grantor's obligation to deliver
Shares upon exercise of the Option is subject only to the conditions that:
(a) No preliminary or permanent injunction or other order issued by
any federal or state court of competent jurisdiction in the United States
prohibiting the delivery of the Shares shall be in effect; and
-2-
(b) Any applicable waiting periods under the Xxxx-Xxxxx-Xxxxxx
Antitrust Improvements Act of 0000 (xxx "XXX Xxx") shall have expired or
been terminated; and
(c) Any other consent, approval, order, notification, or
authorization, the failure of which to obtain or make would make the
issuance of the Shares illegal, shall have been obtained or made and be in
full force and effect; and
(d) (i) any person (other than Grantee or any of its subsidiaries)
shall have acquired beneficial ownership (as such term is defined in Rule
13d-3 under the Securities Exchange Act of 1934, as amended (the "Exchange
Act")) or the right to acquire beneficial ownership of, or any "group" (as
such term is defined under the Exchange Act) shall have been formed which
beneficially owns or has the right to acquire beneficial ownership of,
shares of Common Stock aggregating 20% or more of the then outstanding
Common Stock; (ii) the Merger Agreement shall have been terminated by
Grantor pursuant to Section 8.1(g) of the Merger Agreement; or (iii)
either (A) a Grenada Takeover Proposal shall have been made to Grantor or
any of its subsidiaries or any of its stockholders or any person shall
have publicly announced an intention (whether or not conditional) to make
a Grenada Takeover Proposal with respect to Grantor or any of its
subsidiaries and thereafter the Merger Agreement shall have been
terminated by either Grantee or Grantor pursuant to Section 8.1(d) of the
Merger Agreement, or (B) the Merger Agreement shall have been terminated
by Grantee pursuant to Section 8.1(f) of the Merger Agreement, and, in the
case of either clause (A) or clause (B), within 18 months of the date of
such termination Grantee enters into any Grenada Acquisition Agreement (as
defined in the Merger Agreement). As used in this Agreement, "person"
shall have the meaning specified in Sections 3(a)(9) and 13(d)(3) of the
Exchange Act.
3. The Closing.
(a) Any closing hereunder shall take place on the date specified by
the Grantee in its Stock Exercise Notice or Cash Exercise Notice, as the
case may be, at 9:00 A.M., local time, at the offices of Wachtell, Lipton,
Xxxxx & Xxxx, 00 Xxxx 00xx Xxxxxx, Xxx Xxxx, Xxx Xxxx, xx, if the
conditions set forth in Section 2(a), (b) or (c) have not then been
satisfied, on the second business day following the satisfaction of such
conditions, or at such other time and place as the parties hereto may
agree (the "Closing Date"). On the Closing Date, (i) in the event of a
closing pursuant to Section 1(b) hereof, the Grantor will deliver to the
Grantee a certificate or certificates, representing the Shares in the
denominations designated by the Grantee in its Stock Exercise Notice and
the Grantee will purchase such Shares from the Grantor at the price per
Share equal to the Purchase Price or (ii) in the event of a closing
pursuant to Section 1(c) hereof, the Grantor will deliver to the Grantee
cash in an amount determined pursuant to Section 1(c) hereof. Any payment
made by the Grantee to the Grantor, or by the Grantor to the Grantee,
pursuant to this Agreement shall be made by
-3-
wire transfer to a bank designated by the party receiving such funds.
(b) The certificates representing the Shares shall bear an
appropriate legend relating to the fact that such Shares have not been
registered under the Securities Act of 1933, as amended (the "Securities
Act").
4. Representations and Warranties of the Grantor. The Grantor represents
and warrants to the Grantee that (a) the Grantor is a corporation duly
organized, validly existing and in good standing under the laws of the State of
Delaware and has the requisite corporate power and authority to enter into and
perform this Agreement; (b) the execution and delivery of this Agreement by the
Grantor and the consummation by it of the transactions contemplated hereby have
been duly authorized by the Board of Directors of the Grantor and this Agreement
has been duly executed and delivered by a duly authorized officer of the Grantor
and constitutes a valid and binding obligation of the Grantor, enforceable in
accordance with its terms, subject to bankruptcy, insolvency, fraudulent
transfer, reorganization, moratorium and similar laws of general applicability
relating to or affecting creditors' rights and to general principles of equity;
(c) the Grantor has taken all necessary corporate action to authorize and
reserve the Shares issuable upon exercise of the Option and the Shares, when
issued and delivered by the Grantor upon exercise of the Option and paid for by
Grantee as contemplated hereby, will be duly authorized, validly issued, fully
paid and non-assessable and free of preemptive rights; (d) the execution and
delivery of this Agreement by the Grantor and, except as otherwise required by
the HSR Act and applicable insurance laws and for such filings as are required
by the New York Stock Exchange, Inc. ("NYSE"), the consummation by it of the
transactions contemplated hereby do not require the consent, waiver, approval or
authorization of or any filing with any person or public authority and will not
violate, result in a breach of or the acceleration of any obligation under, or
constitute a default under, any provision of Grantor's certificate of
incorporation or bylaws, or any material indenture, mortgage, lien, lease,
agreement, contract, instrument, order, law, rule, regulation, judgment,
ordinance, or decree, or restriction by which the Grantor or any of its
subsidiaries or any of their respective properties or assets is bound; (e) no
"fair price," "moratorium," "control share acquisition," "interested
shareholder" or other form of antitakeover statute or regulation, including
without limitation, Section 203 of the Delaware General Corporation Law, or
similar provision contained in the certificate of incorporation or bylaws of
Grantor, is or shall be applicable to any of the transactions contemplated by
this Agreement, and the Board of Directors of the Company has taken all action
to approve the transactions contemplated hereby to the extent necessary to avoid
any such application (including, without limitation, the Board of Directors of
the Company having determined pursuant to Article IX of the Company's Restated
Certification of Incorporation that the purchase price under Sections 7 and 8
hereof will not violate or require any shareholder vote under Article X
thereof); and (f) the Grantor has taken all corporate action necessary so that
the grant and any subsequent exercise of the Option by the Grantee or other
exercise by the Grantee of any its rights hereunder will not result in the
separation or exercisability of the rights under the Rights Agreement or in any
nullification of rights under the Rights Agreement held by the Grantee or any of
its Affiliates or Associates (as defined in the Rights Agreement).
5. Representations And Warranties of The Grantee. The Grantee represents
and warrants to the Grantor that (a) the execution and delivery of this
Agreement by the Grantee and the consummation by it of the transactions
contemplated hereby have been duly authorized
-4-
by all necessary corporate action on the part of the Grantee and this Agreement
has been duly executed and delivered by a duly authorized officer of the Grantee
and constitutes a valid and binding obligation of Grantee; and (b) the Grantee
is acquiring the Option and, if and when it exercises the Option, will be
acquiring the Shares issuable upon the exercise thereof for its own account and
not with a view to distribution or resale in any manner which would be in
violation of the Securities Act.
6. Listing of Shares; Filings; Governmental Consents. Subject to
applicable law and the rules and regulations of the NYSE, when the Option
becomes exercisable hereunder, the Grantor will promptly file an application to
list the Shares on the NYSE and will use all reasonable best efforts to obtain
approval of such listing and to effect all necessary filings by the Grantor
under the HSR Act and the applicable insurance laws of each state and foreign
jurisdiction; provided, however, that if the Grantor is unable to effect such
listing on the NYSE by the Closing Date, the Grantor will nevertheless be
obligated to deliver the Shares upon the Closing Date. Each of the parties
hereto will use its reasonable best efforts to obtain consents of all third
parties and governmental authorities, if any, necessary to the consummation of
the transactions contemplated.
7. Repurchase of Shares. If within 18 months after the date the Merger
Agreement was terminated pursuant to the terms thereof (the "Merger Termination
Date"), neither the Grantee nor any other person has acquired more than fifty
percent (excluding the Shares) of the shares of outstanding Common Stock, the
Grantor will then have the right to purchase (the "Repurchase Right") all, but
not less than all, of the Shares acquired upon exercise of this Option of which
the Grantee is the beneficial owner on the date the Grantor gives written notice
of its intention to exercise the Repurchase Right, at the greater of (i) the
Purchase Price or (ii) the average of the last sales prices for shares of Common
Stock on the 30 trading days ending on the date the Grantor gives written notice
of its intention to exercise the Repurchase Right. If the Grantor does not
exercise the Repurchase Right within thirty days following the date the
Repurchase Right becomes exercisable, the Repurchase Right will expire and
cannot thereafter be exercised. In the event the Grantor wishes to exercise the
Repurchase Right, the Grantor shall send a written notice to the Grantee
specifying a date (not later than 20 business days and not earlier than 10
business days following the date such notice is given) for the closing of such
purchase.
8. Sale of Shares. At any time prior to the date that is 18 months after
the Merger Termination Date, the Grantee shall have the right to sell (the "Sale
Right") to the Grantor all, but not less than all, of the Shares acquired upon
exercise of this Option of which the Grantee is the beneficial owner on the date
the Grantee gives written notice of its intention to exercise the Sale Right, at
the greater of (i) the Purchase Price, or (ii) the average of the last sales
prices for shares of Common Stock on the 30 trading days ending on the date the
Grantee gives written notice of its intention to exercise the Sale Right. If the
Grantee does not exercise the Sale Right prior to the date the Sale Right
becomes exercisable, the Sale Right will expire and cannot thereafter be
exercised. In the event the Grantee wishes to exercise the Sale Right, the
Grantee shall send a written notice to the Grantor specifying a date not later
than 20 business days and not earlier than 10 business days following the date
such notice is given for the closing of such sale.
9. Registration Rights.
-5-
(a) In the event that the Grantee shall desire to sell any of the
Shares within three years after the purchase of such Shares pursuant
hereto, and such sale requires, in the opinion of counsel to the Grantee,
which opinion shall be reasonably satisfactory to the Grantor and its
counsel, registration of such Shares under the Securities Act, the Grantor
will cooperate with the Grantee and any underwriters in registering such
Shares for resale, including, without limitation, promptly filing a
registration statement which complies with the requirements of applicable
federal and state securities laws, and entering into an underwriting
agreement with such underwriters upon such terms and conditions as are
customarily contained in underwriting agreements with respect to secondary
distributions; provided that the Grantor shall not be required to have
declared effective more than two registration statements hereunder and
shall be entitled to delay the filing or effectiveness of any registration
statement for up to 90 days if the offering would, in the judgment of the
Board of Directors of the Grantor, require premature disclosure of any
material corporate development or material transaction involving the
Grantor or interfere with any previously planned securities offering by
the Grantor.
(b) If the Common Stock is registered pursuant to the provisions of
this Section 9, the Grantor agrees (i) to furnish copies of the
registration statement and the prospectus relating to the Shares covered
thereby in such numbers as the Grantee may from time to time reasonably
request and (ii) if any event shall occur as a result of which it becomes
necessary to amend or supplement any registration statement or prospectus,
to prepare and file under the applicable securities laws such amendments
and supplements as may be necessary to keep available for at least 90 days
a prospectus covering the Common Stock meeting the requirements of such
securities laws, and to furnish the Grantee such numbers of copies of the
registration statement and prospectus as amended or supplemented as may
reasonably be requested. The Grantor shall bear the cost of the
registration, including, but not limited to, all registration and filing
fees, printing expenses, and fees and disbursements of counsel and
accountants for the Grantor, except that the Grantee shall pay the fees
and disbursements of its counsel, and the underwriting fees and selling
commissions applicable to the shares of Common Stock sold by the Grantee.
The Grantor shall indemnify and hold harmless (i) Grantee, its affiliates
and its officers and directors and each person who controls Grantee within
the meaning of the Securities Act or Exchange Act and (ii) each
underwriter and each person who controls any underwriter within the
meaning of the Securities Act or the Exchange Act (collectively, the
"Underwriters") ((i) and (ii) being referred to as "Indemnified Parties")
against any losses, claims, damages, liabilities or expenses, to which the
Indemnified Parties may become subject, insofar as such losses, claims,
damages, liabilities (or actions in respect thereof) and expenses arise
out of or are based upon any untrue statement or alleged untrue statement
of any material fact contained or incorporated by reference in any
registration statement or prospectus filed pursuant to this paragraph, or
arise out of or are based upon the omission or alleged omission to state
therein a material fact required to be stated therein or necessary to make
the statements therein not misleading; provided, however, that the Grantor
will not be liable in any such case to the extent that any such loss,
liability, claim, damage or expense arises out of or is based upon an
untrue statement or alleged untrue statement in or omission or alleged
omission from any such documents in reliance upon and in conformity with
written information furnished to the Grantor by the Indemnified
-6-
Parties expressly for use or incorporation by reference therein.
(c) The Grantee and the Underwriters shall indemnify and hold
harmless the Grantor, its affiliates and its officers and directors and
each person who controls Grantee within the meaning of the Securities Act
or Exchange Act against any losses, claims, damages, liabilities or
expenses to which the Grantor, its affiliates and its officers and
directors may become subject, insofar as such losses, claims, damages,
liabilities (or actions in respect thereof) and expenses arise out of or
are based upon any untrue statement of any material fact contained or
incorporated by reference in any registration statement filed pursuant to
this paragraph, or arise out of or are based upon the omission or alleged
omission to state therein a material fact required to be stated therein or
necessary to make the statements therein not misleading, in each case to
the extent, but only to the extent, that such untrue statement or alleged
untrue statement or omission or alleged omission was made in reliance upon
and in conformity with written information furnished to the Grantor by the
Grantee or the Underwriters, as applicable, specifically for use or
incorporation by reference therein.
10. Expenses. Each party hereto shall pay its own expenses incurred in
connection with this Agreement, except as otherwise specifically provided
herein.
11. Specific Performance. The Grantor acknowledges that if the Grantor
fails to perform any of its obligations under this Agreement immediate and
irreparable harm or injury would be caused to the Grantee for which money
damages would not be an adequate remedy. In such event, the Grantor agrees that
the Grantee shall have the right, in addition to any other rights it may have,
to specific performance of this Agreement. Accordingly, if the Grantee should
institute an action or proceeding seeking specific enforcement of the provisions
hereof, the Grantor hereby waives the claim or defense that the Grantee has an
adequate remedy at law and hereby agrees not to assert in any such action or
proceeding the claim or defense that such a remedy at law exists. The Grantor
further agrees to waive any requirements for the securing or posting of any bond
in connection with obtaining any such equitable relief.
12. Notice. All notices, requests, demands and other communications
hereunder shall be deemed to have been duly given and made if in writing and if
served by personal delivery upon the party for whom it is intended or delivered
by registered or certified mail, return receipt requested, or if sent by
facsimile transmission, upon receipt of oral confirmation that such transmission
has been received, to the person at the address set forth below, or such other
address as may be designated in writing hereafter, in the same manner, by such
person:
If to the Grantee:
Berkshire Hathaway Inc.
0000 Xxxxxx Xxxxx
Xxxxx, XX 00000
Attn: Xxxxxx X. Xxxxxxx
Fax: (000) 000-0000
With a copy to:
-7-
Xxxxxx, Xxxxxx & Xxxxx LLP
000 Xxxxx Xxxxx Xxxxxx
Xxx Xxxxxxx, XX 00000
Attn: R. Xxxxxxx Xxxxxx, Esq.
Fax: (000) 000-0000
If to the Grantor:
General Re Corporation
000 Xxxx Xxxx Xxxxxx
Xxxxxxxx, XX 00000
Attn: Xxxxxxx X. Xxxx, General Counsel
Fax: (000) 000-0000
With a copy to:
Wachtell Lipton Xxxxx & Xxxx
00 Xxxx 00xx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
Attn: Xxxxxx X. Xxxxxxx
Fax: (000) 000-0000
13. Parties in Interest. This Agreement shall inure to the benefit of and
be binding upon the parties named herein and their respective successors and
assigns. Nothing in this Agreement, express or implied, is intended to confer
upon any person other than the Grantor or the Grantee, or their successors or
assigns, any rights or remedies under or by reason of this Agreement.
14. Entire Agreement; Amendments. This Agreement, together with the Merger
Agreement and the other documents referred to therein, contains the entire
agreement between the parties hereto with respect to the subject matter hereof
and supersedes all prior and contemporaneous agreements and understandings, oral
or written, with respect to such transactions. This Agreement may not be
changed, amended or modified orally, but may be changed only by an agreement in
writing signed by the party against whom any waiver, change, amendment,
modification or discharge may be sought.
15. Assignment. No party to this Agreement may assign any of its rights or
obligations under this Agreement without the prior written consent of the other
party hereto, except that the Grantee may assign its rights and obligations
hereunder to any of its direct or indirect wholly owned subsidiaries, but no
such transfer shall relieve the Grantee of its obligations hereunder if such
transferee does not perform such obligations.
16. Headings. The section headings herein are for convenience only and
shall not affect the construction of this Agreement.
-8-
17. Counterparts. This Agreement may be executed in any number of
counterparts, each of which, when executed, shall be deemed to be an original
and all of which together shall constitute one and the same document.
18. Governing Law. This Agreement shall be governed by and construed in
accordance with the laws of the State of Delaware (without regard to principles
of conflicts of law).
19. Termination. The right to exercise the Option granted pursuant to this
Agreement shall terminate at the earliest of (i) the Effective Time (as defined
in the Merger Agreement) (ii) if the Option is not exercised within 120 days
after first becoming exercisable and (iii) if not then exercisable, 30 days
after termination of the Merger Agreement in accordance with its terms (the
dates referred to in clause (ii) and (iii) being hereinafter referred to as the
"Termination Date"); provided that, if the Option cannot be exercised or the
Shares cannot be delivered to Grantee upon such exercise because the conditions
set forth in Section 2(a), (b) or (c) hereof have not yet been satisfied, the
Termination Date shall be extended until 30 days after such impediment to
exercise or delivery has been removed. All representations and warranties
contained in this Agreement shall survive delivery of and payment for the
Shares.
20. Profit Limitation.
(a) Notwithstanding any other provision of this Agreement or the
Merger Agreement, in no event shall the Grantee's Total Profit (as
hereinafter defined) exceed $600 million and, if it otherwise would exceed
such amount, the Grantee shall repay such excess amount to Grantor in cash
(or the purchase price for purposes of Section 7 or 8, as applicable,
shall be reduced) so that Grantee's Total Profit shall not exceed $600
million after taking into account the foregoing actions.
(b) Notwithstanding any other provision of this Agreement, this
Option may not be exercised for a number of Shares as would, as of the
date of the Stock Exercise Notice, result in a Notional Total Profit (as
defined below) of more than $600 million and, if exercise of the Option
otherwise would exceed such amount, the Grantee, at its discretion, may
increase the Purchase Price for that number of Shares set forth in the
Stock Exercise Notice so that the Notional Total Profit shall not exceed
$600 million; provided, that nothing in this sentence shall restrict any
exercise of the Option permitted hereby on any subsequent date at the
Purchase Price set forth in Section 1(a) hereof.
(c) As used herein, the term "Total Profit" shall mean the aggregate
amount (before taxes) of the following: (i) (x) the amount of cash
received by Grantee pursuant to Section 8.2 of the Merger Agreement and
Section 1(c) hereof, less (y) any repayment of such cash to Grantor, (ii)
(x) the amount received by Grantee pursuant to the Grantor's repurchase of
Shares pursuant to Sections 7 or 8 hereof, less (y) the Grantee's purchase
price for such Shares, and (iii) (x) the net cash amounts received by
Grantee pursuant to the sale of Shares (or any other securities into or
for which such Shares are converted or exchanged) to any unaffiliated
party, less (y) the Grantee's purchase price for such Shares.
-9-
(d) As used herein, the term "Notional Total Profit" with respect to
any number of Shares as to which Grantee may propose to exercise this
Option shall be the Total Profit determined as of the date of the Stock
Exercise Notice assuming that this Option were exercised on such date for
such number of Shares and assuming that such Shares, together with all
other Shares acquired upon exercise of the Option and held by Grantee and
its affiliates as of such date, were sold for cash at the closing market
price for the Common Stock as of the close of business on the preceding
trading day (less customary brokerage commissions).
21. Severability. If any term, provision, covenant or restriction of this
Agreement is held by a court of competent jurisdiction to be invalid, void or
unenforceable, the remainder of the terms, provisions, covenants and
restrictions of this Agreement shall remain in full force and effect and shall
in no way be affected, impaired or invalidated.
-10-
IN WITNESS WHEREOF, the Grantee and the Grantor have caused this Agreement
to be duly executed and delivered on the day and year first above written.
GENERAL RE CORPORATION
By: /s/ Xxxxxx X. Xxxxxxxx
----------------------
Xxxxxx X. Xxxxxxxx
Chairman and Chief Executive Officer
BERKSHIRE HATHAWAY INC.
By: /s/ Xxxxxx X. Xxxxxxx
---------------------
Xxxxxx X. Xxxxxxx
Chairman and Chief Executive Officer
-11-
